Synthetic peptides fail to induce nasal tolerance to experimental autoimmune myasthenia gravis

Journal of Neuroimmunology

Volumn 85, Issue 1, 1998, Pages 96-101

  Zhang, Guang Xian ^a   Shi, Fu Dong ^a   Zhu, Jie ^a   Xiao, Bao Guo ^a   Levi, Michael ^b   Wahren, Britta ^b   Yu, Li Ya ^a   Link, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

AChR peptide; Experimental autoimmune myasthenia gravis; Mucosal tolerance

Indexed keywords

CHOLINERGIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TORPEDO;

ANIMALS; ANTIBODIES; FEMALE; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; MUSCLES; MYASTHENIA GRAVIS; NASAL CAVITY; PEPTIDE FRAGMENTS; RATS; RATS, INBRED LEW; RECEPTORS, CHOLINERGIC; TORPEDO;

EID: 0032078671     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00243-9     Document Type: Article

References (27)

1. Araga S., LeBoeuf R.D., Blalock J.E. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8747-8751.
2. Åhlberg R., Yi Q., Eng H., Pirskanen R., Lefvert A.K. T-cell epitope on the human AChR α-subunit residues 10-84 in myasthenia gravis. Scand. J. Immunol. 36:1992;422-435.
3. Daniel D., Wegmann D.R. Protection of nonbese diabetic mice from diabetes by transnasal or subcutaneous administration of insulin peptide B-9-(23). Proc. Natl. Acad. Sci. U.S.A. 93:1996;956-960.
4. Drachman D.B. Myasthenia gravis. New Engl. J. Med. 330:1994;1797-1810.
5. Fujii Y., Lindstrom J. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis. J. Immunol. 141:1988;3361-3369.
6. Hawke S., Matsuo H., Nicolle M., Malcherek G., Melms A., Willcox N. Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting. Immunol. Today. 7:1996;307-311.
7. Lindstrom J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptor. Meth. Enzymol. 74:1981;432-460.
8. Link H., Xu Z.Y., Melms A., Kalbacher H., Sun J.B., Wang Z.Y., Fredrikson S., Olsson T. The T-cell repertoire in myasthenia gravis involves multiple cholinergic receptor epitopes. Scand. J. Immunol. 36:1992;405-414.
9. Loutrari H., Kokla A., Tzartos S.J. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor. Eur. J. Immunol. 22:1992;2449-2452.
10. Ma C.G., Zhang G.X., Xiao B.G., Link J., Olsson T., Link H. Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Neuroimmunol. 58:1995;51-60.
11. Matsuo H., Batocchi A.P., Hawke S., Nicolle M., Jacobson L., Vincent A., Newsom-Davis J., Willcox N. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. J. Immunol. 155:1995;3683-3692.
12. Metzler B., Wraith D.C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5:1993;1159-1165.
13. Okumura S., McIntosh K., Drachman D.B. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis. Ann. Neurol. 36:1994;704-713.
14. Pullen G.R., Fitzgerald M.G., Hosking C.S. Antibody avidity determination by ELISA using thiocynate elution. J. Immunol. Meth. 86:1986;83-87.
15. Shenoy M., Oshima M., Atassi M.Z., Christadoss P. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region α 146-162 of acetylcholine receptor. Clin. Immunol. Immunopathol. 66:1993;230-238.
16. Souroujon M.C., Carmon S., Fuchs S. Modulation of anti-acetylcholine receptor antibody specificities and of experimental autoimmune myasthenia gravis by synthetic peptides. Immunol. Lett. 34:1992;19-25.
17. Spack E.G., McCutheon M., Corbelletta N., Nag B., Passmore D., Sharma S.D. Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II: acetylcholine receptor peptide complex. J. Autoimmun. 8:1995;787-807.
18. Staines N.A., Harper N., Ward F.J., Malmstrom V., Holmdahl R., Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 103:1996;368-375.
19. Takamori M., Okumura S., Nagata M., Yoshikawa H. Myasthenogenic significance of synthetic alpha-subunit peptide 183-200 of Torpedo californica and human acetylcholine receptor. J. Neurol. Sci. 85:1988;121-129.
20. Thompson P.A., McAtee R., Infante A.J., Currier P., Beninati W., Krolick K.A. V beta-specific immunotoxin selectively kills acetylcholine receptor-reactive T lymphocytes from mice with experimental autoimmune myasthenia gravis. Int. Immunol. 6:1994;1807-1815.
21. Wang Z.Y., Qiao J., Melms A., Link H. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental myasthenia gravis. Cell. Immunol. 152:1993;394-405.
22. Wang Z.Y., Huang J., Olsson T., Bing H., Link H. B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J. Neurol. Sci. 128:1995;167-174.
23. Wraith D.C. Antigen-specific immunotherapy of autoimmune disease: a commentary. Clin. Exp. Immunol. 103:1996;349-352.
24. Yeh T.M., Krolick K.A. T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function. J. Immunol. 144:1990;1654-1660.
25. Zhang Y., Barkas T., Juillerrat M., Schwendimann B., Wekerle H. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between district segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo Californica). Eur. J. Immunol. 18:1988;551-557.
26. Zhang G.X., Ma C.G., Xiao B.G., van der Meide, Link H. Autoreactive T cell responses and cytokine patterns reflect resistance against experimental autoimmune myasthenia gravis in Wistar Furth rats. Eur. J. Immunol. 26:1996;2552-2558.
27. Zoda T.E., Brandon K., Krolick K.A. Neonatal tolerance to an immunodominant T cell reactivity does not confer resistance to EAMG induction in Lewis. J. Neuroimmunol. 57:1995;35-44.